Primatene Mist To Be Unavailable After 2010 – Proposed Rule
This article was originally published in The Tan Sheet
Executive Summary
Wyeth will allow its epinephrine-containing Primatene Mist metered-dose inhaler to be phased out of the market after 2010, rather than reformulating to comply with an FDA proposed rule published in the Sept. 20 Federal Register